METHOD OF TREATING EXPERIMENTAL PANCREATONECROSIS Russian patent published in 2014 - IPC G09B23/28 A61K31/549 A61P1/18 

FIELD: medicine.

SUBSTANCE: invention refers to experimental medicine and can be used to work out drug therapy of acute pancreatonecrosis with its efficacy to be followed by a histological study. That is ensured by simulating pancreatonecrosis in animals. That is followed by intravenous introduction of the compound "2-morpholino-5-phenyl-6H-1,3,4-thiadiazine hydrobromide" of 1,3,4-thiadiazines in a dose of 40 mg/kg.

EFFECT: method provides effective treatment of pancreatonecrosis, including by managing an acute phase of a systemic inflammatory response, increasing a probability of the recovery, and reducing a mortality.